benphothiamine has been researched along with Cognition Disorders in 3 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we report that long-term administration of benfotiamine improved the cognitive ability of patients with AD." | 1.43 | Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer's Disease. ( Bao, W; Chen, Z; Fei, G; Guan, Y; Pan, S; Pan, X; Ren, S; Zhong, C, 2016) |
| " Here, we tested the effect of benfotiamine, a thiamine derivative with better bioavailability than thiamine, on cognitive impairment and pathology alterations in a mouse model of Alzheimer's disease, the amyloid precursor protein/presenilin-1 transgenic mouse." | 1.36 | Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice. ( Chen, J; Dong, W; Fei, G; Gong, N; Gu, F; Pan, X; Qin, Y; Sun, X; Xu, TL; Xu, Z; Yu, M; Yu, Z; Zhao, J; Zhao, L; Zhong, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, X | 2 |
| Chen, Z | 1 |
| Fei, G | 2 |
| Pan, S | 1 |
| Bao, W | 1 |
| Ren, S | 1 |
| Guan, Y | 1 |
| Zhong, C | 2 |
| Markova, N | 1 |
| Bazhenova, N | 1 |
| Anthony, DC | 1 |
| Vignisse, J | 1 |
| Svistunov, A | 1 |
| Lesch, KP | 1 |
| Bettendorff, L | 1 |
| Strekalova, T | 1 |
| Gong, N | 1 |
| Zhao, J | 1 |
| Yu, Z | 1 |
| Gu, F | 1 |
| Chen, J | 1 |
| Sun, X | 1 |
| Zhao, L | 1 |
| Yu, M | 1 |
| Xu, Z | 1 |
| Dong, W | 1 |
| Qin, Y | 1 |
| Xu, TL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety and Efficacy of Qualia Mind on Cognition in a Healthy Population[NCT04389723] | 60 participants (Actual) | Interventional | 2020-05-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for benphothiamine and Cognition Disorders
| Article | Year |
|---|---|
Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer's Disease.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Chromatograph | 2016 |
Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Topics: Animals; Avoidance Learning; Brain; Cognition Disorders; Conditioning, Psychological; Disease Models | 2017 |
Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cerebral Cortex; Cognition; Cognition Diso | 2010 |